IRIS
MANZIA, TOMMASO MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 23.887
AS - Asia 5.203
EU - Europa 3.199
Continente sconosciuto - Info sul continente non disponibili 668
SA - Sud America 660
AF - Africa 95
OC - Oceania 15
Totale 33.727
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 23.642
SG - Singapore 2.707
CN - Cina 832
IT - Italia 745
RU - Federazione Russa 523
BR - Brasile 521
HK - Hong Kong 438
VN - Vietnam 386
DE - Germania 344
FI - Finlandia 266
GB - Regno Unito 265
IE - Irlanda 242
UA - Ucraina 210
BD - Bangladesh 199
FR - Francia 161
IN - India 142
JP - Giappone 142
CA - Canada 132
KR - Corea 104
NL - Olanda 94
SE - Svezia 88
ES - Italia 56
MX - Messico 52
AR - Argentina 48
ID - Indonesia 46
PL - Polonia 44
TR - Turchia 44
AT - Austria 40
BE - Belgio 27
CO - Colombia 26
ZA - Sudafrica 25
IQ - Iraq 21
EC - Ecuador 20
EG - Egitto 20
CZ - Repubblica Ceca 18
AU - Australia 14
CH - Svizzera 14
JM - Giamaica 14
MY - Malesia 14
VE - Venezuela 13
NG - Nigeria 12
PH - Filippine 12
SA - Arabia Saudita 12
TH - Thailandia 12
GR - Grecia 11
CL - Cile 10
KE - Kenya 10
HR - Croazia 9
UZ - Uzbekistan 9
HN - Honduras 8
IR - Iran 8
JO - Giordania 8
EU - Europa 7
TN - Tunisia 7
AE - Emirati Arabi Uniti 6
AZ - Azerbaigian 6
GT - Guatemala 6
LT - Lituania 6
MA - Marocco 6
MD - Moldavia 6
PK - Pakistan 6
PY - Paraguay 6
UY - Uruguay 6
CR - Costa Rica 5
IL - Israele 5
NP - Nepal 5
PE - Perù 5
PT - Portogallo 5
TT - Trinidad e Tobago 5
DO - Repubblica Dominicana 4
DZ - Algeria 4
HU - Ungheria 4
KG - Kirghizistan 4
LK - Sri Lanka 4
NI - Nicaragua 4
RO - Romania 4
TM - Turkmenistan 4
BO - Bolivia 3
DK - Danimarca 3
KH - Cambogia 3
KZ - Kazakistan 3
MT - Malta 3
PR - Porto Rico 3
PS - Palestinian Territory 3
SN - Senegal 3
SV - El Salvador 3
TW - Taiwan 3
AM - Armenia 2
BB - Barbados 2
BY - Bielorussia 2
EE - Estonia 2
KW - Kuwait 2
LB - Libano 2
ML - Mali 2
NO - Norvegia 2
PA - Panama 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AG - Antigua e Barbuda 1
AL - Albania 1
Totale 33.042
Salva come PNG Salva come JPEG
Città #
Wilmington 5.240
Houston 4.834
Woodbridge 4.195
Singapore 1.242
Ashburn 819
Fairfield 770
San Jose 673
Ann Arbor 470
New York 467
Chandler 438
Hong Kong 423
Council Bluffs 346
Beijing 344
Seattle 309
Cambridge 282
Santa Clara 254
Dublin 231
Helsinki 200
Los Angeles 192
Medford 178
Jacksonville 174
The Dalles 154
Rome 145
Tokyo 128
Ho Chi Minh City 120
Buffalo 108
Zhengzhou 101
Hanoi 94
Elk Grove Village 88
Moscow 84
Lawrence 83
Lauterbourg 78
Dearborn 72
São Paulo 69
Denver 67
Chicago 66
Milan 59
Orem 58
Boardman 56
Dallas 52
San Diego 52
Atlanta 49
London 46
Creede 45
North Bergen 43
Munich 41
Chennai 40
Montreal 35
Brooklyn 34
Menlo Park 34
Shanghai 31
Jakarta 30
Toronto 30
Frankfurt am Main 28
Mülheim 28
Warsaw 26
Nuremberg 25
Phoenix 25
Manchester 23
Nanjing 23
Amsterdam 22
Johannesburg 22
Palo Alto 22
Poplar 22
Redondo Beach 22
Turin 22
Lappeenranta 21
San Francisco 21
Stockholm 21
Vienna 21
Brussels 20
Mexico City 19
Washington 17
Brasília 16
Miami 16
Mountain View 16
Norwalk 16
Redwood City 16
Salt Lake City 16
Seoul 16
Verona 16
Jersey City 15
Rio de Janeiro 15
Ankara 14
Dong Ket 14
Hefei 13
Madrid 13
Engelhard 12
Guangzhou 12
Istanbul 12
Naples 12
Padua 12
Belo Horizonte 11
Columbus 11
Genoa 11
Mumbai 11
Boston 10
Da Nang 10
Haiphong 10
Palermo 10
Totale 25.079
Salva come PNG Salva come JPEG
Nome #
Elective surgery system strengthening: development, measurement, and validation of the surgical preparedness index across 1632 hospitals in 119 countries 719
Complete weaning off immunosuppression in HCV liver transplant recipients is feasible and favourably impacts on the progression of disease recurrence. 548
HCV-RNA quantification in liver bioptic samples and extrahepatic compartments, using the abbott RealTime HCV assay 537
Re-Evaluation of the Role of Antifibrinolytic Therapy with Lysine Analogs in Liver Transplantation in The Post-Aprotinin Era 525
Deep vein thrombosis as debut of cytomegalovirus infection associated with type ii cryoglobulinemia, with antierythrocyte specificity in a kidney transplant recipient: A case report 511
Successful management of a same-day emergency delivery and liver transplant in a 27 weeks pregnant woman with fulminant hepatic failure. 510
Hepatitis C virus recurrence and immunosuppression-free state after liver transplantation. 505
Ab initio calcineurin inhibitor-based monotherapy immunosuppression after liver transplantation reduces the risk for Pneumocystis jirovecii pneumonia. 502
Glycogen storage disease type Ia and VI associated with hepatocellular carcinoma: Two case reports 500
Use of mycophenolate mofetil in liver transplantation: a literature review. 494
Impact of immunosuppression minimization and withdrawal in long-term hepatitis C virus liver transplant recipients 494
Amantadine monotherapy is ineffective in the treatment of hepatitis C virus recurrence in the post-liver transplantation setting. 484
Primary yolk sac tumor of the liver: incidental finding in a patient transplanted for hepatocellular carcinoma 483
Marginal donors in liver transplantation. 482
Relationship between GH/IGF-1 Axis, graft recovery, and early survival in patients undergoing liver transplantation 482
596 474
Steroid-free immunosuppression after liver transplantation does not increase the risk of graft fibrosis. 467
Amantadine monotherapy is ineffective in the treatment of hepatitis C virus recurrence in the post-liver transplantation setting 460
Pitfalls in the reporting of upper endoscopy features in cirrhotic patients 459
Management of spermatic cord liposarcoma in renal transplant recipients: case report 457
Liver abscess caused by foreign body ingestion 456
Long-term, maintenance MMF monotherapy improves the fibrosis progression in liver transplant recipients with recurrent hepatitis C 451
Complete hbv prophylaxis withdrawal in HBsAg-positive liver transplant recipients after long-term minimal immunosuppression 451
The Tor Vergata weaning off immunosuppression protocol in stable HCV liver transplant patients: the updated follow up at 78 months. 449
Immunosuppression-Free Liver Transplantation 443
Liver transplantation in primary hepatic carcinoid tumor: case report and literature review. 441
Intra-graft expression of genes involved in iron homeostasis predicts the development of operational tolerance in human liver transplantation. 438
Liver transplantation for the treatment of nodular regenerative hyperplasia 433
Side-to-side caval anastomosis in a patient receiving a liver graft from a marginal donor with situs inversus totalis 433
The Tor Vergata weaning of immunosuppression protocols in stable hepatitis C virus liver transplant patients: the 10-year follow-up 429
One-shot versus multidose perioperative antibiotic prophylaxis after kidney transplantation: A randomized, controlled clinical trial 427
Different expression of VEGF and EGFL7 in human hepatocellular carcinoma 426
Surgical antibiotic prophylaxis after renal transplantation: time to reconsider. 423
Radiofrequency-assisted right hemihepatectomy by using a new incremental bipolar generator combined with liver hanging maneuver. 422
Prospect for kidney bioengineering: Shortcomings of the status quo 403
Myopericytoma of the Liver Hilus: A Case Report 393
Ab initio Everolimus-based Versus Standard Calcineurin Inhibitor Immunosuppression Regimen in Liver Transplant Recipients 387
Switch from twice-daily tacrolimus (Prograf) to once-daily prolonged-release tacrolimus (Advagraf) in kidney transplantation. 386
Combined liver transplantation and sleeve gastrectomy for end-stage liver disease in a bariatric patient: First European case-report 382
Liver transplantation for hepatitis B and C virus-related cirrhosis: mid-term results 372
An unusual duodenal polyp causing anemia in a liver-transplanted patient 357
Clinical Operational Tolerance and Immunosuppression Minimization in Kidney Transplantation: Where Do We Stand? 357
Longterm Survival and Cost-Effectiveness of Immunosuppression Withdrawal After Liver Transplantation 348
Hepatitis B virus recurrence after liver transplantation: An old tale or a clear and present danger? 342
Donation after circulatory death in paediatric liver transplantation: current status and future perspectives in the machine perfusion era 331
Impact of remnant vital tissue after locoregional treatment and liver transplant in hepatocellular cancer patients, a multicentre cohort study 321
Direct-acting antivirals and hepatocellular carcinoma in chronic hepatitis C: A few lights and many shadows 318
Effect of direct-acting antivirals on future occurrence of hepatocellular carcinoma in compensated cirrhotic patients 310
Liver transplantation with a normothermic machine preserved fatty nonagenarian liver: A case report 307
Recurrence of hepatocellular carcinoma after direct acting antiviral treatment for hepatitis C virus infection: Literature review and risk analysis 301
Renal Function, Adherence and Quality of Life Improvement After Conversion From Immediate to Prolonged-Release Tacrolimus in Liver Transplantation: Prospective Ten-Year Follow-Up Study 288
HCV resistance compartmentalization within tumoral and non-tumoral liver in transplanted patients with hepatocellular carcinoma 275
Pandora’s Box: Unpredictable Evolution of a 20-Year History of a Bariatric Patient—Report of Small Bowel Migrated Gastric Band after Redo Banded Gastric Bypass 266
Liver Transplantation For HDV/HBV Coinfection In Italy: An Intention-To-Treat Analysis Of Long-Term Outcomes 261
Rare malignant glomus tumor of the stomach with liver metastases 245
Platelets and hepatocellular cancer: Bridging the bench to the clinics 240
Everolimus and enteric-coated mycophenolate sodium Ab initio after liver transplantation: Midterm results 238
Intention-to-treat survival benefit of liver transplantation in patients with hepatocellular cancer 234
The COVID-19 outbreak in Italy: initial implications for organ transplantation programs 231
De novo malignancies after liver transplantation: The effect of immunosuppression-personal data and review of literature 219
Evaluation of Contrast-Enhanced Intraoperative Ultrasound in the Detection and Management of Liver Lesions in Patients with Hepatocellular Carcinoma 215
Liver transplantation for hepatocellular carcinoma: Where do we stand? 214
Everolimus and Advagraf Ab Initio in Combined Liver and Kidney Transplant With Donor-Specific Antibodies: A Case Report 214
Liver transplantation in a patient with complete portal vein thrombosis, is there a surgical way out? A case report 211
Vascular anomalies of the celiac trunk and implications in treatment of HCC with TACE. Description of a case and review of the literature 207
How do synchronous lung metastases influence the surgical management of children with hepatoblastoma? An update and systematic review of the literature 205
Screening of Fabry Disease of patients in renal replacement therapy in a population from Lazio (Italy) 204
Switch From Twice-daily Tacrolimus to Once-daily, Prolonged-release Tacrolimus in Kidney Transplantation: Long-term Outcome 202
Abdominal organ bioengineering: current status and future perspectives 194
The Intention-to-Treat Effect of Bridging Treatments in the Setting of Milan Criteria–In Patients Waiting for Liver Transplantation 190
Using a weaning immunosuppression protocol in liver transplantation recipients with hepatocellular carcinoma: A compromise between the risk of recurrence and the risk of rejection? 189
Immunosuppression in adult liver transplant recipients: a 2024 update from the Italian Liver Transplant Working Group 174
Laparoscopic adrenalectomy for hemorrahagic adrenal pseudocyst discovered during pregnancy: Report of a case 171
Fairness and pitfalls of the Italian waiting list for elective liver transplantation: The ECALITA registry study 163
The hamletic dilemma of patients waiting for kidney transplantation during the COVID-19 pandemic: to accept or not to accept (an organ offer)? 143
Moving forward in the treatment of cholangiocarcinoma 137
Prognostic Factors for 10-Year Survival in Patients With Hepatocellular Cancer Receiving Liver Transplantation 134
Serum Levels of Granulocyte-Macrophage-colony-stimulating Factor and Stem-cell Factor During Liver Regeneration after Partial Hepatectomy in Humans 128
Current strategies to minimize ischemia-reperfusion injury in liver transplantation: a systematic review 127
The Enhanced Recovery after Surgery (ERAS) Pathway Is a Safe Journey for Kidney Transplant Recipients during the “Extended Criteria Donor” Era 119
Chronic rejection after liver transplantation: Opening the Pandora's box 118
A Keynesian perspective on the health economics of kidney transplantation would strengthen the value of the whole organ donation and transplantation service 116
“Salus Populi Suprema Lex”: Considerations on the Initial Response of the United Kingdom to the SARS-CoV-2 Pandemic 116
Overview of prognostic systems for hepatocellular carcinoma and ITA.LI.CA external validation of MESH and CNLC classifications 115
Pancreatic Adeno-MiNEN, a Rare Newly Defined Entity with Challenging Diagnosis and Treatment: A Case Report with Systematic Literature Review and Pooled Analysis 114
Cancer mortality after kidney transplantation: A multicenter cohort study in Italy 112
Safety and efficacy of simultaneous liver transplantation and sleeve gastrectomy in morbid obese patients with end-stage liver disease: the LT-SG study 111
Superiority of the new sex-adjusted models to remove the female disadvantage restoring equity in liver transplant allocation 108
Successful clinical and virological outcomes of liver transplantation for HDV/HBV-related disease after long-term discontinuation of hepatitis B immunoglobulins 108
The Enhanced Recovery After Surgery Pathway Is Safe, Feasible and Cost-Effective in Delayed Graft Function After Kidney Transplant 108
Cell transplantation-based regenerative medicine in liver diseases 107
The role of antiplatelet therapies on incidence and mortality of hepatocellular carcinoma 107
Liver transplantation performed in a SARS-CoV-2 positive hospitalized recipient using a SARS-CoV-2 infected donor 106
Mechanism, potential, and concerns of immunotherapy for hepatocellular carcinoma and liver transplantation 106
Intraductal Papillary Neoplasms of the Bile Duct: Clinical Case Insights and Literature Review 104
Waiting list mortality and 5-year transplant survival benefit of patients with MASLD: An Italian liver transplant registry study 103
Temporal trends of waitlistings for liver transplantation in Italy: the ECALITA (Evolution of IndiCAtion in LIver transplantation in ITAly) registry study 102
A 3-month, multicenter, randomized, open-label study to evaluate the impact on wound healing of the early (vs delayed) introduction of everolimus in De Novo Kidney transplant recipients, with a follow-up evaluation at 12 months after transplant (NEVERWOUND study) 102
Correction to: Immunosuppressive regimens for adult liver transplant recipients in real-life practice: consensus recommendations from an Italian Working Group (Hepatology International, (2020), 14, 6, (930-943), 10.1007/s12072-020-10091-5) 100
High-priority liver transplantation and simultaneous sleeve gastrectomy in MELD 32 end-stage liver disease: a case report with long-term follow-up 100
Totale 30.031
Salva come PNG Salva come JPEG
Categoria #
all - tutte 102.416
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 102.416
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022744 0 0 0 32 24 92 61 28 114 112 54 227
2022/20231.362 137 118 15 144 106 247 106 250 100 12 92 35
2023/2024676 76 38 81 17 93 163 32 12 16 37 8 103
2024/20254.082 93 753 446 230 39 283 305 115 324 339 665 490
2025/20267.116 587 285 621 669 683 444 890 895 801 566 389 286
2026/20271.894 327 266 953 348 0 0 0 0 0 0 0 0
Totale 33.727